Piramal Pharma reported a 350% rise in Q2 FY25 net profit to ₹22.59 crore, with revenue climbing 17.3% to ₹2,241.75 crore. Strong performances in CDMO and CHG businesses boosted earnings and margins.
Piramal Pharma reported a 350% rise in Q2 FY25 net profit to ₹22.59 crore, with revenue climbing 17.3% to ₹2,241.75 crore. Strong performances in CDMO and CHG businesses boosted earnings and margins.